ETHOSUXIMIDE

Common Tradename
ZARONTIN
Class
anticonvulsant
Dosage, Adult (usual)
initial 500mg daily (QD-BID), maintenance 20-30mg/kg daily (QD-BID), MAX 1.5g/day
Dosage, Pediatric, (usual)
initial: 3-6years: 250mg/day QD; over 6 years:500 mg/day QD
maint: 20-30mg/kg/day
Dose Adjustments:
severe renal impairment
How Supplied
250 MG CAPSULE
250 MG/5 ML SOLUTION
250 MG/5 ML SYRUP
Indications
absence seizures
Contraindications
hypersensitivity to succinimides
Adverse Effects
blood dyscrasias
ataxia
headache
N/V
drowsiness
Drug Interactions
carbamazepine
evening primrose oil
fosphenytoin
ginkgo
phenobarbital
phenytoin
Pregnancy Category
C
Breast Feeding
controversial
Notes
sudden withdrawal may precipitate seizures

REFERENCE: MICROMEDEX(R) Healthcare Series Vol. 111 expires 3/2002

DESIGNED BY HASHIM TAYEB (Bsc PHARM)